Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Agile Therapeutics, Inc. (AGRX) had Weighted-Average Shares Outstanding (Diluted) of 2.16M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$19.59M |
|
$-14.46M |
|
$8.98M |
|
$10.62M |
|
$39.48M |
|
$-19.88M |
|
$5.42M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
$-19.88M |
|
$-18.43M |
|
2.16M |
|
Weighted-Average Shares Outstanding (Diluted) |
2.16M |
$-6.71 |
|
$-6.71 |
|
Balance Sheet Financials | |
$9.53M |
|
$0.07M |
|
$0.72M |
|
$10.26M |
|
$20.78M |
|
-- |
|
$5.80M |
|
$26.57M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
2.96M |
|
Cash Flow Statement Financials | |
$-9.58M |
|
-- |
|
$6.89M |
|
$5.25M |
|
$2.56M |
|
$-2.69M |
|
$1.98M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.46 |
|
-- |
|
-- |
|
-- |
|
-0.10 |
|
54.18% |
|
-101.49% |
|
-101.49% |
|
-94.09% |
|
-73.83% |
|
-73.83% |
|
$-9.58M |
|
-- |
|
-- |
|
-- |
|
1.91 |
|
3.28 |
|
5.78 |
|
63.19 |
|
88.64% |
|
88.64% |
|
-141.05% |
|
88.64% |
|
$-5.51 |
|
$-4.44 |
|
$-4.44 |